The AstraZeneca PLC ADR AZN rose 1.30% to $73.79 Friday, on what proved to be an all-around rough trading session for the ...

AstraZeneca PLC closed 14.73% below its 52-week high of £133.88, which the company achieved on September 3rd.

Deutsche Bank Research raises Next price target to 10,800 (9,700) pence - 'hold' Deutsche Bank Research raises Imperial Brands price target to 3,250 (2,850) pence - 'buy' Deutsche Bank Research cuts ...

Hi, this is Colum Murphy, writing from the coastal town of Boao, where China is stepping up its charm offensive and pitching ...

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre ...

In the most recent trading session, Astrazeneca (AZN) closed at $72.72, indicating a -0.45% shift from the previous trading day.

Johnson & Johnson has pulled ahead of rival AstraZeneca Plc in a race to dominate the blockbuster market for lung cancer ...

Chancellor Rachel Reeves is set to announce welfare cuts and a boost to defence spending when she delivers a statement to ...

(Alliance News) - AstraZeneca PLC on Tuesday reported positive new study results for its lung cancer drug Tagrisso, strengthening its position as a "backbone" treatment for patients with EGFR-mutated ...

Britain's FTSE 100 index saw a slight decline of 0.1%, with mining stocks offering some stability in light of losses across ...

AstraZeneca is making a $1bn investment for the long term, but what lies in store for investors over the next 12 months? Here ...

The tech-heavy Nasdaq Composite index recently entered correction territory. Though it was able to climb out of it, equities ...